While the exact mechanisms behind Metformins potential weight loss effects are not fully understood, its ability to regulate blood sugar levels and improve insulin function may play a role
Finan B, Yang B, Ottaway N et al (2014) A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Risk of diabetic retinopathy complications in patients with pre-existing retinopathy Potential for acute kidney injury, particularly related to dehydration Caution or avoidance in severe gastroparesis or severe gastrointestinal disease Suicidality warning for weight-management indications (Wegovy, Saxenda) Potential for altered absorption of oral medications due to delayed gastric emptying In older adults with cognitive impairment, medication adherence may be challenging, and gastrointestinal side effects could lead to dehydration or nutritional deficiencies
[5] [1] Following standard pharmacokinetic principles, it takes approximately five half-lives for a medication to be substantially eliminated from the body, which equates to roughly 25 days for tirzepatide
A team from Harvard University started looking into the possible link after three people taking semaglutide the active ingredient in Ozempic and Wegovy were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) within a week
